One hundred and ninety-three patients with hematological malignancies and a follow-up у1 year, treated with stem cell transplantation (45 autologous, 99 allogeneic T cell-depleted matched, 49 allogeneic T cell-depleted mismatched) from July 1985 to May 1998, were considered evaluable for the development of cataracts. Total body irradiation (TBI), administered either according to a hyperfractionated scheme (HTBI) or in a single dose (STBI), was employed in the conditioning regimens. HTBI was prescribed in 94% of patients undergoing allogeneic matched transplant, while STBI was used in 71% of patients receiving allogeneic mismatched and in all patients undergoing autologous transplant. The median follow-up was 7.56 years in the HTBI and 3.02 years in the STBI group. Among the different risk factors analyzed by univariate analysis only the TBI scheme and type of transplant reached statistical significance (P Ͻ 0.0001 and P Ͻ 0.001, respectively). By multivariate analysis only the TBI scheme was an independent factor for cataract development (STBI vs HTBI RR 7.2; P Ͻ 0.01). Our results showed that STBI is more cataractogenic than HTBI. The incidence of cataract we observed was among the lowest described in the literature. T cell depletion, because it prevents graft-versus-host disease and reduces the protracted use of post-transplant steroids, explains the results we obtained. Bone Marrow Transplantation (2002) 29, 503-507. DOI: 10.1038/sj/bmt/1703400 Keywords: cataract; total body irradiation; stem cell transplantation Advances in transplant techniques over the past 20 years have improved long-term survival of patients receiving bone marrow transplant (BMT) and, consequently, have
allowed recognition of the late effects of treatment, such as cataracts. Its incidence has been reported in 3% to 100% of cases. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] Different risk factors for cataract formation have been described in the literature, these being conditioning regimen, type of transplant, age, acute or chronic graft-versus-host disease (GVHD), steroids and previous prophylactic cranial radiotherapy. 1, 4, 5, 7, 9, 10, 13, 17 Both the use of total body irradiation (TBI) in the pre-transplant regimen and the TBI schedule have been proven to be two of the most important risk factors for the development of cataracts. 1, 4, 6, 7, 9, 10, 13 Cataract due to radiation is typically posterior, subcapsular, and different from nuclear cataract located in the central part of the lens, which is usually associated with advanced age.
Other than the risk factors cited above, the large variability in cataract incidence reported in different studies could depend both on length of follow-up 10 and the generally small number of surviving patients at the end of the longest follow-up. This is because when only a few patients remain, even a small number of cataracts can considerably raise the probability of this late effect.
We evaluated the risk of and risk factors for cataract formation in 193 patients receiving two different TBI schedules in their pre-transplant regimen.
Patients and methods
One hundred and ninety-three patients (133 males, 60 females; median age 33 years, range 2-59) with hematological malignancies who underwent BMT and/or peripheral blood stem cell transplantation (PBSCT) at our institution between July 1985 and May 1998 were considered evaluable for the development of cataracts. All had a follow-up of at least 1 year and received regular ophthalmological examinations. Written consent was obtained from patients or, in the case of minors, parents, as well as from donors. Forty-five patients received autologous, 99 allogeneic T cell-depleted matched and 49 allogeneic T cell-depleted mismatched BMT and/or PBSCT. Characteristics of patients are detailed in Table 1. TBI was administered either according to a hyperfractionated scheme (HTBI) or in a single dose (STBI). It was delivered by a 18 MV linear accelerator to all but the first 33 patients, who received HTBI and were treated with a 60 Cobalt Unit. Details of the TBI techniques adopted have been published previously. [18] [19] [20] HTBI was administered three times a day, 5 or 6 h apart, in all but two patients who received 2 Gy twice a day for 3 days. The median single dose was 1.2 Gy (range 1.2-2), median total dose 14.4 Gy (range 12-15.6). In the STBI group the median dose was 8 Gy (range 7-8.5). The median instantaneous dose rate was 9.54 cGy/min/midplane (range 5.47-14.7) in the HTBI and 16 cGy/min/midplane (range 12.4-31.7) in the STBI group. HTBI was employed in almost all patients who underwent allogeneic matched transplantation (93 of 99; 93.94%), while STBI was used in the majority of patients who received allogeneic mismatched (35 of 49; 71%) and in all patients receiving autologous transplantation (Table 1) .
TBI was the first treatment administered to all patients, followed by the chemotherapy schemes described in past studies. [18] [19] [20] [21] [22] [23] [24] The rationale behind the use of the different pre-transplant schedules, selected according to the type of transplant, has been explained previously. [18] [19] [20] [21] 25 Ophthalmological examinations were carried out before transplant, 6 and 12 months after, and subsequently yearly. Each patient underwent visual acuity testing, tonometry, slit-lamp and fundus examination after pupillary dilatation. As in other past reports, posterior subcapsular cataract was defined as the presence of vacuolar opacities beneath the posterior lens capsule. 10 Patients with cataracts prior to transplant, either congenital or acquired, were excluded from the analysis.
Statistical analysis
On univariate survival analysis, different risk factors were analyzed: age (categorized as Ͻ30 years and у30 years), type of transplant, GVHD, steroid therapy, TBI scheme. Furthermore, for each TBI scheme, a different dose rate value, categorized as Ͻ9 and у9 cGy/min in the HTBI and Ͻ16 and у16 cGy/min in the STBI group was analyzed. The choice of dose rate cut-off was based on the value at the 50th percentile in the two schedules. The probability of developing cataracts was calculated applying the KaplanMeier method and analyzed by the log-rank test. Previous prophylactic cranial radiotherapy, which was given to two acute lymphoid leukemia patients (one in the HTBI, one in the STBI group) as central nervous system prophylaxis, was not analyzed as a risk factor. TBI dose was not examined because 77.6% of patients received 14.4 Gy in the HTBI and 86% of patients received 8 Gy in the STBI group. Multivariate analysis was performed applying the Cox regression model.
Results
The median follow-up was 7.56 years (range 1.14-14.86) in the HTBI and 3.02 years (range 1.13-7.28) in the STBI group. Cataracts were observed in 14 of the 107 (13%) patients who had undergone HTBI and in 18 of the 86 (21%) patients who had received STBI; in all but two cases they were bilateral. Median time for development was 7.6 years (range 1.16-14) after HTBI and 2.52 years (range 1.33-5.57) after STBI. The hazard rate of cataract development was distributed throughout years 1-10 among patients who received HTBI, while it was greatest between the second and third year in patients treated with STBI. Two patients in the HTBI (14.3%) and 11 in the STBI (61.1%) group required surgery (P Ͻ 0.002). The two patients in the HTBI group were 45 and 52 years old, while the median age of the patients in the STBI group was 47 years (range 8-58). The decision to perform surgery was based upon patient vision in the context of lifestyle. Notwithstanding this, all patients receiving surgery had a visual acuity р5/10.
Among the different risk factors tested on univariate analysis only the TBI scheme and type of transplant reached statistical significance ( Table 2 ). The probability of developing cataracts was 23 ± 6% at 10 years and 74 ± 21% at 14 years in the HTBI group. In the STBI group the probability at 5 years was 41 ± 9% (P Ͻ 0.0001) (Figure 1 ). The probability was 42 ± 12% at 5 years after autologous, 27 ± 8% at 3 years after allogeneic mismatched, whereas after allogeneic matched transplant it was 25 ± 7% at 10 years, and reached 75 ± 20% at 14 years (P Ͻ 0.001) (Figure 2) . The results observed at 14 years in the HTBI group and in allogeneic matched BMT patients depended on two late events occurring in two of the three remaining patients who survived more than 14 years.
Multivariate survival analysis showed that only the TBI scheme reached statistical significance (STBI vs HTBI RR 7.2, P Ͻ 0.01).
Discussion
Different risk factors for cataract formation such as conditioning regimen, type of transplant, age, acute or chronic GVHD, steroids and previous prophylactic cranial radiotherapy have been reported after stem cell transplantation.
1,4,5,7,9,10,13,17 Among the factors related to conditioning regimen, TBI is the most important and the TBI parameters that can influence cataract development are fractionation, total dose, and dose rate. 1, 4, 6, 7, 9, 10, 13, [26] [27] [28] In our series, of all the risk factors analyzed on univariate analysis only the TBI scheme and type of transplant proved to be statistically significant. Regarding the TBI scheme, administration in a single dose was more cataractogenic and was associated with an increased need for surgery. Furthermore, the hazard rate of cataract development was very different between the two groups; it was greatest between years 2 and 3 among patients who received STBI, while in the HTBI group it was distributed throughout years 1-10.
Bone Marrow Transplantation It should be noted that estimates in the final years were calculated on a very small number of patients and consequently the standard deviation was high. The median follow-up of 3.02 years in the STBI group did not permit longterm evaluation, as was possible in the HTBI group, where the follow-up was longer and two late events were observed at 14 years. This strongly suggests that patients risk developing cataracts at any time following TBI. In the HTBI group the probability of developing cataracts at 10 years was lower than reported by others over the same period. 9, 10 We believe that the hyperfractionated scheme we selected, which utilized a median of 12 fractions of 1.2 Gy, allowed sparing of the lens. In fact more than six fractions were associated with a lower risk of cataract formation in the European Group for Blood and Marrow Transplantation (EBMT) Registry series. 13 Furthermore, the low incidence of GVHD observed, due to the T cell depletion technique adopted, and the small number of patients treated with steroids, explain the results we obtained. The low incidence of GVHD and the small number of patients treated with steroids also influenced the results observed in the STBI group, where the probability of cataracts at 5 years was in line with the lowest reported in the literature at the same time. 8, 13 In other reports, a lower incidence of cataracts was seen with the selection of a low dose rate, after both fractionated TBI and STBI. [26] [27] [28] In our study dose rate was not shown to be a risk factor by univariate analysis, after either HTBI, or STBI. This could have depended on the fact that the median dose rate value was higher than those used in other studies. Moreover, in the HTBI group the number of fractions employed could have influenced the results obtained. In fact, more than six fractions was linked to the disappearance of the importance of dose rate in the EBMT Registry series. 13 Very few studies have analyzed type of transplant as a risk factor for cataracts and the results obtained by univariate analysis have been contradictory. 10, 17, 28 In our series, type of transplant, which was significant by univariate analysis, lost its significance by multivariate analysis, where it emerged as a confounding factor due to its strong association with the TBI schedule. Therefore, only the TBI scheme proved to be an independent factor for cataract development by multivariate analysis, which showed STBI to be more cataractogenic than HTBI (RR 7.2; P Ͻ 0.01).
In some studies, GVHD and steroids proved to be risk factors for cataracts. 1, 5, [8] [9] [10] 17 The lack of significance seen in our study is due to the small number of patients who developed GVHD and/or were treated with steroids for a long time and the small number of patients who developed cataracts.
In our series, as in most others, age at transplant did not influence the incidence of cataracts, 1, 4, 9, 10, [28] [29] [30] while the opposite was found in the EBMT Group study. 13 The results of our study identified, among all the tested risk factors, TBI as the sole cause of cataract formation. Both HTBI and STBI triggered cataracts but after STBI the risk of developing this late effect was significantly higher and the latent period between transplant and cataract formation was shorter. Furthermore, cataracts observed after STBI required surgery more frequently. Nevertheless, the incidence of cataracts that we observed was among the lowest described in the literature, after either HTBI or STBI. T cell depletion, because it prevents GVHD and reduces the protracted use of post-transplant steroids, explains the results we obtained.
